谢雷星张波盖兢泾李娟刘宏斌△.阿加曲班用于肝素相关性血小板减少症患者PCI 术抗凝治疗1 例
并文献复习[J].,2012,12(9):1674-1676 |
阿加曲班用于肝素相关性血小板减少症患者PCI 术抗凝治疗1 例
并文献复习 |
Argatroban Anticoagulation During Percutaneous Coronary Intervention inPatients With Heparin-Induced Thrombocytopenia:One Case Report andReview of Literature |
|
DOI: |
中文关键词: 肝素相关性血小板减少症 经皮冠状动脉介入治疗 阿加曲班 |
英文关键词: Heparin-induced thrombocytopenia Percutaneous transluminal coronary intervention Argatroban |
基金项目: |
|
摘要点击次数: 955 |
全文下载次数: 971 |
中文摘要: |
目的:探讨肝素相关性血小板减少症(heparin-induced thrombocytopenia,HIT)患者行经皮冠状动脉介入治疗(percutaneous
transluminal coronary intervention,PCI)术中及术后使用阿加曲班进行抗凝的效果及安全性。方法:报道并回顾性分析阿加曲班用
于肝素相关性血小板减少症患者PCI 术一例并进行文献复习。结果:患者女性,55 岁,皮下注射低分子肝素4 天后血小板由
140×109/L 下降为17×109/L,患者出现牙龈出血、左前臂出现瘀斑,诊断为HIT。行冠状动脉支架植入术术中及术后使用阿加曲
班抗凝,未出现出血及血栓事件。结论:肝素相关性血小板减少症患者行PCI 术,术中及术后采用阿加曲班进行抗凝治疗是有效
安全的。 |
英文摘要: |
Objective: To study the effiency and safety of argatroban anticoagulation during percutaneous coronary intervention in
patients with heparin-induced thrombocytopenia (HIT). Methods: One case of argatroban anticoagulation during PCI in Patients With
HIT was reported with its related literature reviewed. Results: The patient was a 55-year old female whose blood platelet was reduced
from 140×109/L to 17×109/L with gingival bleeding and bruisesafter on the left forearm after subcutaneous injection of Low-Molecular-
Weight Heparins four days,and was diagnosed HIT. No bleeding and thrombotic events happened when preoperative and postoperative
using of argatroban for PCI. Conclusion: Argatroban can be used as an anticoagulant agent for PCI in patients with HIT. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |